In same regard, the lack of LATS1/2 reduced the inhibitory effects of the STARD13-correlated ceRNA network on EMT features of CSC, indicating that the tumor-suppressive effects of the STARD13-correlated ceRNA network are mediated by LATS1/2 modulation [82]. The gene discussed is STARD13; the disease is neoplasm.